Evidence map›Paper›PMID 37958685›Full record

ArticleInternational journal of molecular sciences2023

Kento Takaya, Toru Asou, Kazuo Kishi

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Effects ofNutrients · 2025
    Trial
  2. Review
  3. Article
  4. Article
  5. The AntioxidantAntioxidants (Basel, Switzerland) · 2026
    Article
  6. 2-Methoxystypandrone fromAntioxidants (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Nutrition research and practice · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Quality evaluation ofFrontiers in nutrition · 2025
    Article
  14. Senolytic Prodrugs: A Promising Approach to Enhancing Senescence-Targeting Intervention.Chembiochem : a European journal of chemical biology · 2024
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kento TakayaDepartment of Plastic and Reconstructive Surgery, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Toru AsouDepartment of Plastic and Reconstructive Surgery, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Kazuo KishiDepartment of Plastic and Reconstructive Surgery, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
Keio University · JP

Funding

Japan Society for the Promotion of Science JP 22K19589
6 · The paper itself

Abstract

Dermal fibroblasts maintain the skin homeostasis by interacting with the epidermis and extracellular matrix. Their senescence contributes to functional defects in the skin related to aging. Therefore, there is an urgent need for novel therapeutic agents that could inhibit fibroblast senescence. In this study, we investigated the effects of

Indexed as

CistancheNF-E2-Related Factor 2AgingCells, CulturedCellular SenescenceFibroblastsHumansHydrogen PeroxideInflammationPhenotypePolysaccharidesReactive Oxygen SpeciesHydrogen PeroxideNF-E2-Related Factor 2PolysaccharidesReactive Oxygen SpeciesCistanche desserticolafibroblastsrejuvenationSASPskin aging

Identifiers

PMID37958685
PMCPMC10647235
OpenAlexW4388021251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.